Evidence map›Paper›PMID 21571962›Full record

ArticleAmerican journal of clinical pathology2011

Flow cytometric immunophenotypic assessment of T-cell clonality by Vβ repertoire analysis: detection of T-cell clonality at diagnosis and monitoring of minimal residual disease following therapy.

Prashant Tembhare, Constance M Yuan, Liqiang Xi, John C Morris, David Liewehr, David Venzon, John E Janik, Mark Raffeld, Maryalice Stetler-Stevenson

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in American journal of clinical pathology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. The Diagnostic Utility of TRBC1 Immunohistochemistry in Mature T-Cell Lymphomas.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2025
    Article
  5. The CXCL10-CXCR3 axis plays an important role in Kawasaki disease.Clinical and experimental immunology · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Prashant TembhareFlow Cytometry Unit, Laboratory of Pathology, National Cancer Institute/NIH, Bethesda, MD 20892, USA.
Constance M Yuan
Liqiang Xi
John C Morris
David Liewehr
David Venzon
John E Janik
Mark Raffeld
Maryalice Stetler-Stevenson
Center for Cancer Research · USNational Cancer Institute · USNational Institutes of Health · US

Funding

Molecular Diagnostics Core LaboratoryZICBC011079 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI XI, LIQIANG · 2009 to 2025
$33.8M
Flow Cytometric Analysis of Benign and Malignant TumorsZICSC009372 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI WANG, HAO-WEI · 2009 to 2025
$29.6M
Office of Collaborative BiostatisticsZIDSC007202 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI CHOO-WOSOBA, HYOYOUNG · 2009 to 2025
$14.5M
Flow Cytometric Evaluation of BiomarkersZ01BC011104 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI STETLER-STEVENSON, MARYALICE · 2008 to 2008
$368k
Intramural NIH HHS Z01 BC011104
6 · The paper itself

Abstract

Flow cytometric T-cell receptor (TCR)-V(β) repertoire analysis (TCR-V(β)-R) is a sensitive method for detection of T-cell clonality; however, no uniform approach exists to define clonality in neoplastic T cells. TCR-V(β)-R was evaluated in patients with a diagnosis of T-cell neoplasia in initial diagnostic specimens from 41 patients and for minimal residual disease (MRD) monitoring in 61 sequential samples from 14 patients with mature T-cell neoplasia. Gating strategies and criteria for detection of T-cell clonality were determined. In all 41 initial specimens, T-cell clonality was demonstrated via TCR-V(β)-R. The frequency of V(β) usage was consistent with random neoplastic transformation of TCR-V(β) subsets. MRD was successfully detected in follow-up samples from all 14 patients evaluated, Furthermore, MRD after therapy was quantitated in 48 peripheral blood specimens. TCR-V(β)-R analysis is a sensitive method for detection of T-cell clonality and is useful for diagnosis and MRD detection in multiple specimen types.

Indexed as

Flow CytometryAdolescentAdultAgedAged, 80 and overCell Transformation, NeoplasticClone CellsFemaleGene Rearrangement, beta-Chain T-Cell Antigen ReceptorHTLV-I InfectionsHumansImmunophenotypingLeukemia, T-CellLymphoma, T-CellMaleMiddle AgedReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID21571962
PMCPMC7384354
OpenAlexW1967324333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.